Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
J. Urol., Apr;183(4):1469-73 (2010)
UHPLC separation with MS analysis for eight carbonyl compounds in mainstream tobacco smoke.
J Chromatogr Sci., Jan;48(1):12-7 (2010)
Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link.
Curr Urol Rep., Jul;9(4):314-9 (2008)
Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms.
Rev Urol., 9(2):73-7 (2007)
Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Eur. Urol., Jun;51(6):1717-23 (2007)
A case of incidental adrenocortical oncocytoma.
Nat Clin Pract Urol., Nov;3(11):618-21 (2006)
Refractory overactive bladder in men: update on novel therapies.
Curr Urol Rep., Nov;7(6):456-61 (2006)
Is there a role for urodynamics in chronic nonbacterial prostatitis?
Curr Urol Rep., Jul;7(4):335-8 (2006)
Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention.
Urology., Aug;68(2):312-7 (2006)
Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Expert Opin Drug Metab Toxicol., Aug;2(4):609-17 (2006)
Arteriovenous malformation of scrotum causing virtual azoospermia.
Urology., Jul;68(1):203.e5-6 (2006)
First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment?
World J Urol., Sep;24(4):360-6 (2006)
The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia.
World J Urol., Sep;24(4):405-9 (2006)
Photoselective laser vaporization prostatectomy in men receiving anticoagulants.
J. Endourol., Dec;19(10):1196-8 (2005)
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
Urology., May;65(5):931-6 (2005)
Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis.
J. Urol., Feb;173(2):630-4 (2005)
Chronic prostatitis and sensory urgency: whose pain is it?
Curr Urol Rep., Dec;5(6):437-41 (2004)